Figure 3 — Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

Research Paper|Volume 15, Issue 16|pp. 8155–8184

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

Back to articleFigure 3(3 of 12)

100%

Figure 3.Relationship between RP2 and prognosis of glioma patients. Glioma patients with lower expression level of RP2 had favorable (A) OS (HR = 2.37, p < 0.001), (B) DSS (HR = 2.54, p < 0.001), (C) PFS (HR = 1.98, p < 0.001). (D) Nomograms and (E) calibration curves.